Hemolytic anemia occurs when your body destroys red blood cells faster than new ones can be produced. It has many causes, including genetic disorders, infections, and autoimmune diseases.

Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm ...

About IgG4-RD IgG4-RD affects approximatively eight out of 100,000 adult patients in the US each year and is a rare, progressive, relapsing, chronic fibro-inflammatory condition which can manifest in ...

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

Four cases of Coombs-positive hemolytic anemia have been described in which the administration of penicillin to patients with circulating antipenicillin antibody was the suspected cause of the ...

Hemolytic anemia occurs when red blood cells are broken up in the bloodstream or in the spleen. It may be due to mechanical problems (leaky heart valves or aneurysms), infections, autoimmune ...

Considering taking supplements to treat hemolytic anemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hemolytic anemia. Follow the links to read common uses ...

Sanofi's rilzabrutinib receives FDA orphan drug designation for two rare diseases. Clinical studies show meaningful response rates and reduced disease flares.

Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune hemolytic an ...